Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04426513
Other study ID # Magnetotherapy/ RA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 20, 2020
Est. completion date November 30, 2020

Study information

Verified date August 2021
Source University of Rzeszow
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants with rheumatoid arthritis with recommendation to physiotherapy. Created 3 study groups: 1. Only kinesiotherapy 2. Kinesiotherapy with unipolar magnetic field 3. Kinesiotherapy with bipolar magnetic field Kinesiotherapy with magnetic field give better effects than only kinesiotherapy.


Description:

Participants with rheumatoid arthritis with recommendation to physiotherapy. All participants have dysfunction and pain of hand. Inclusion criteria: 1. II ° and III ° of advancement of radiological changes 2. II ° and III ° of advancement of functional changes 3. Remission, low or moderate RA activity: DAS28 4. Medical order 1. Magnetotherapy and kinesiotherapy 2. Kinesiotherapy 3. Consent to participate in the study 4. Completion of the research program Exclusion criteria: 1. Additional physiotherapy treatments for the hands 2. Change in type or dose of pharmacotherapy used 3. Taking steroid anti-inflammatory drugs 4. Malaise and side effects in the subject Outcome Measures: 1. Duration of morning stiffness 2. The degree of severity of morning stiffness 3. Pain intensity assessment (VAS) 4. Test Box & Blocks 5. Measurement of the palmar surface of the hand 6. Measuring the range of motion in the joints of the hand 7. Measurement of compression force in a cylindrical grip 8. Time to maintain maximum pressure during cylindrical grip 9. Hand volume measurement 10. HAQ-20 test Intervention: 1. Group 1: Only kinesiotherapy 2. Group 2: Kinesiotherapy with bipolar magnetic field 3. Group 3: Kinesiotherapy with unipolar magnetic field Assessment: 1. Immediately before start therapy 2. Immediately after therapy (10 treatments in 2 weeks)


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date November 30, 2020
Est. primary completion date November 30, 2020
Accepts healthy volunteers No
Gender All
Age group 35 Years to 80 Years
Eligibility Inclusion Criteria: - II ° and III ° of advancement of radiological changes - II ° and III ° of advancement of functional changes - Remission, low or moderate RA activity: DAS28 - Medical order - Magnetotherapy and kinesiotherapy - Kinesiotherapy - Consent to participate in the study - Completion of the research program Exclusion Criteria: - Additional physiotherapy treatments for the hands - Change in type or dose of pharmacotherapy used - Taking steroid anti-inflammatory drugs - Malaise and side effects in the subject

Study Design


Intervention

Other:
Kinesiotherapy with magnetotherapy
Individual kinesiotherapy. Parameters of magnetic field: 7 mT, f= 0-50 Hz, type of impulse: unipolar or bipolar, rectangular pulse

Locations

Country Name City State
Poland St. Hedvig Clinical Provincial Hospital No. 2, ul. Lwowska 60 Rzeszów Subcarpathian

Sponsors (1)

Lead Sponsor Collaborator
Jolanta Zwolinska

Country where clinical trial is conducted

Poland, 

References & Publications (5)

Erol K, Gok K, Cengiz G, Ozgocmen S. Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables. Int J Rheum Dis. 2018 Jan;21(1):249-252. doi: 10.1111/1756-185X.13044. Epub 2017 Mar 21. — View Citation

Nasonov VA, Murav'ev IuV, Kuz'mina NN. [Can local therapy of joint syndrome with Dolgit cream be used as an alternative to systemic nonsteroid antiinflammatory drugs in rheumatic diseases?]. Ter Arkh. 1998;70(11):64-6. Russian. — View Citation

Richmond SJ. Magnet therapy for the relief of pain and inflammation in rheumatoid arthritis (CAMBRA): a randomised placebo-controlled crossover trial. Trials. 2008 Sep 12;9:53. doi: 10.1186/1745-6215-9-53. — View Citation

Srikesavan C, Williamson E, Cranston T, Hunter J, Adams J, Lamb SE. An Online Hand Exercise Intervention for Adults With Rheumatoid Arthritis (mySARAH): Design, Development, and Usability Testing. J Med Internet Res. 2018 Jun 27;20(6):e10457. doi: 10.2196/10457. — View Citation

Zwolinska J, Gasior M, Sniezek E, Kwolek A. The use of magnetic fields in treatment of patients with rheumatoid arthritis. Review of the literature. Reumatologia. 2016;54(4):201-206. Epub 2016 Oct 5. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) Pain severity rating scale. only one value. Minimum value is 0, maximum value is 10. The best is 0, the worst is 10. Change from baseline VAS value immediately after therapy
Primary Health Assesment Questionaire (HAQ) Subjective assesment of level of disability. Value of each of 8 subsections: minimum value 0, maximum value 3. total score is averaged. The best total score is 0, the worst is 3. Change from baseline HAQ value immediately after therapy
Secondary Test Box&Blocks Objective assessment of level of disability of hand. Number of blocks transfer from box 1 to box 2 during 1 minute. Change from baseline number of blocks immediately after therapy.
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4